BTA-9881

BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.

1646857-24-0

≥ 2 years

>98% (HPLC)

390.82

C21H15ClN4O2

Research use only, not for human use.

RSV

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

GX3007-1kg 1 Kg

Ask

NBP1-46179F 0.1 mL

Ask

NBP2-75985-0.1mL 0.1 mL

Ask

MBS8291732-01 0.03 mL

Ask

MBS8291732-02 0.05 mL

Ask

MBS8291732-03 0.1 mL

Ask